3/23
08:50 am
jspr
Rating for JSPR
Low
Report
Rating for JSPR
3/23
08:42 am
jspr
Jasper Therapeutics (JSPR) is now covered by UBS Group AG. They set a "neutral" rating and a $1.50 price target on the stock.
Low
Report
Jasper Therapeutics (JSPR) is now covered by UBS Group AG. They set a "neutral" rating and a $1.50 price target on the stock.
1/13
03:20 pm
jspr
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
Low
Report
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
1/13
03:20 pm
jspr
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
Low
Report
Jasper Therapeutics initiated with a Buy at Rodman & Renshaw
1/13
10:58 am
jspr
Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
Low
Report
Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
1/13
10:58 am
jspr
Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.
Low
Report
Jasper Therapeutics (NASDAQ:JSPR) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $17.00 price target on the stock.